You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Mallinckrodt
Harvard Business School
AstraZeneca
Boehringer Ingelheim

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

Bupivacaine hydrochloride; lidocaine hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for bupivacaine hydrochloride; lidocaine hydrochloride and what is the scope of patent protection?

Bupivacaine hydrochloride; lidocaine hydrochloride is the generic ingredient in one branded drug marketed by Amphastar Pharms Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for bupivacaine hydrochloride; lidocaine hydrochloride.

Summary for bupivacaine hydrochloride; lidocaine hydrochloride
Recent Clinical Trials for bupivacaine hydrochloride; lidocaine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
St. Joseph's Healthcare HamiltonPhase 2
University of Missouri-ColumbiaPhase 4
Obstetric Anaesthetists' AssociationPhase 4

See all bupivacaine hydrochloride; lidocaine hydrochloride clinical trials

US Patents and Regulatory Information for bupivacaine hydrochloride; lidocaine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amphastar Pharms Inc DUOCAINE bupivacaine hydrochloride; lidocaine hydrochloride INJECTABLE;INJECTION 021496-001 May 23, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
McKinsey
Medtronic
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.